These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8315933)
1. Treatment and prevention of hyperkalemia in end-stage renal disease. Allon M Kidney Int; 1993 Jun; 43(6):1197-209. PubMed ID: 8315933 [No Abstract] [Full Text] [Related]
2. Approach to hyperkalemic end-stage renal disease patients in the emergency department. Perazella MA Conn Med; 1999 Mar; 63(3):131-6. PubMed ID: 10218288 [No Abstract] [Full Text] [Related]
3. Hyperkalemia in dialysis patients. Ahmed J; Weisberg LS Semin Dial; 2001; 14(5):348-56. PubMed ID: 11679104 [TBL] [Abstract][Full Text] [Related]
4. Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia. Salem MM; Rosa RM; Batlle DC Am J Kidney Dis; 1991 Oct; 18(4):421-40. PubMed ID: 1928061 [TBL] [Abstract][Full Text] [Related]
5. Hyperkalemia in hemodialysis patients. Pani A; Floris M; Rosner MH; Ronco C Semin Dial; 2014; 27(6):571-6. PubMed ID: 25039770 [TBL] [Abstract][Full Text] [Related]
10. Medical and dialytic management of hyperkalemia in hemodialysis patients. Allon M Int J Artif Organs; 1996 Dec; 19(12):697-9. PubMed ID: 9029244 [No Abstract] [Full Text] [Related]
11. Control of serum potassium during fasting in patients with end-stage renal disease. Gifford JD; Rutsky EA; Kirk KA; McDaniel HG Kidney Int; 1989 Jan; 35(1):90-4. PubMed ID: 2651754 [TBL] [Abstract][Full Text] [Related]
12. Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence. Evans K; Reddan DN; Szczech LA Semin Dial; 2004; 17(1):22-9. PubMed ID: 14717808 [TBL] [Abstract][Full Text] [Related]
13. [State of the cardiovascular system in chronic renal insufficiency]. Sumarokov AV; Mikhaĭlov AA; Moiseev VS Kardiologiia; 1969 Aug; 9(8):128-35. PubMed ID: 4906927 [No Abstract] [Full Text] [Related]
14. The role of aldosterone blockade in end-stage renal disease. Pitt B; Saran R Cardiology; 2009; 114(1):30-1. PubMed ID: 19342856 [No Abstract] [Full Text] [Related]
15. [Hyperkalemia]. Le Gall JR Nouv Presse Med; 1974 May; 3(21):1391-2. PubMed ID: 4848890 [No Abstract] [Full Text] [Related]
16. The hyperkalemia of renal failure: pathophysiology, diagnosis and therapy. Kupin WL; Narins RG Contrib Nephrol; 1993; 102():1-22. PubMed ID: 8416175 [No Abstract] [Full Text] [Related]
17. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease. Allon M; Dansby L; Shanklin N Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392 [TBL] [Abstract][Full Text] [Related]
18. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Kim HJ Nephron; 1996; 72(3):476-82. PubMed ID: 8852501 [TBL] [Abstract][Full Text] [Related]
19. [Hyperkalemia in the chronic renal failure: is it always the aldosterone the responsible?]. Martin R; Arrizurieta de Muchnik E Medicina (B Aires); 1982; 42(4):445-7. PubMed ID: 15171028 [No Abstract] [Full Text] [Related]